James B. Breitmeyer - Insider Trading & Ownership

Entity
Individual
Summary
The estimated net worth of James B. Breitmeyer is at least $325K dollars as of February 15, 2024. James B. Breitmeyer is the Chief Executive Officer, Director of Oncternal Therapeutics, Inc. and owns shares of Oncternal Therapeutics, Inc. (ONCT) stock worth about $325K.
All Insider Reports
All Insider Reports

Ownership of James B. Breitmeyer

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ONCT Oncternal Therapeutics, Inc. Chief Executive Officer, Director $325K Feb 14, 2024
OTIC OTONOMY, INC. Director Jun 21, 2022
ZGNX ZOGENIX, INC. Director Mar 7, 2022

Insider Transactions Reported by James B. Breitmeyer:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.